JP Stock MarketDetailed Quotes

4553 TOWA Pharmaceutical

Watchlist
  • 2840
  • -8-0.28%
20min DelayMarket Closed Feb 27 15:30 JST
146.31BMarket Cap8.64P/E (Static)

TOWA Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TOWA Pharmaceutical Q3 2025 Earnings Date

Currency：JPYFeb 13, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
70.10B
70.33B
+229.67M
Beat Est.
+15.06%
+15.43%
+0.33%
EPS
57.66
163.91
+106.25
Beat Est.
-37.85%
+76.73%
+184.28%
Analyst Rating
Strong Buy

Feb 13, 2025

TOWA Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 69.486B--
Feb 13, 20252025/Q370.333B / 70.103B--
Nov 12, 20242025/Q260.838B / 59.733B--
Aug 8, 20242025/Q162.566B / 61.500B--
May 14, 20242024/Q459.609B / 61.606B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 69.486B--
Feb 13, 20252025/Q370.333B / 70.103B--
Nov 12, 20242025/Q260.838B / 59.733B--
Aug 8, 20242025/Q162.566B / 61.500B--
May 14, 20242024/Q459.609B / 61.606B--

Unlock Free Earnings Estimates

TOWA Pharmaceutical Earnings Reports

  • TOWA Pharmaceutical: Notice regarding revisions to dividend forecasts for the fiscal year ending March 31, 2025 (69th term)

    Feb 13 01:30 ET

  • TOWA Pharmaceutical: Supplementary explanation of financial results for the 3rd quarter of the fiscal year ending March 31, 2025

    Feb 13 01:30 ET

  • TOWA Pharmaceutical: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)

    Feb 13 01:30 ET

  • TOWA Pharmaceutical: Confirmation letter

    Nov 12, 2024 19:01 ET

    • Read more

    Top JP Stock Gainers
    Symbol Price % Chg
    Smile Holdings
    7084
    1349 +28.60%
    p-ban.com
    3559
    635 +18.69%
    atect
    4241
    511 +18.56%
    Architects Studio Japan
    6085
    517 +18.31%
    Generation Pass
    3195
    650 +18.18%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Feb 13, 2025

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      0.00%

    • Hold

      25.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data